These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34719735)

  • 21. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR; Ji SQ; Wang HX; Yan HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
    Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
    Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.
    Kim H; Kang HJ; Lee JW; Park KD; Shin HY; Ahn HS
    Ann Hematol; 2012 May; 91(5):751-758. PubMed ID: 22076065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
    Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A
    Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Hama A; Kudo K; Nishio N; Muramatsu H; Tanaka M; Yoshida N; Matsumoto K; Watanabe N; Kato K; Horibe K; Kojima S
    Bone Marrow Transplant; 2010 Oct; 45(10):1508-13. PubMed ID: 20118992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation.
    Hussein AA; Sharma S; Al-Zaben A; Frangoul H
    Pediatr Transplant; 2014 Sep; 18(6):625-30. PubMed ID: 25041793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia.
    Sun ZM; Liu HL; Geng LQ; Wang XB; Yao W; Liu X; Ding KY; Han YS; Yang HZ; Tang BL; Tong J; Zhu WB; Wang ZY
    J Hematol Oncol; 2010 Dec; 3():51. PubMed ID: 21194460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation.
    Aksu T; Ok Bozkaya İ; Akpınar Tekgündüz S; Olcar Kanbur M; Köksal Y; Özgüner M; Özbek NY
    Transfus Apher Sci; 2017 Dec; 56(6):829-831. PubMed ID: 29153311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
    Kim H; Lee KH; Sohn SK; Kim I; Kim SH; Park Y; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Choi Y;
    Acta Haematol; 2020; 143(3):232-243. PubMed ID: 31390612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S
    Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
    Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK; Bollard CM; Krance RA
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1277-84. PubMed ID: 17162209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
    Couban S; Aljurf M; Lachance S; Walker I; Toze C; Rubinger M; Lipton JH; Lee SJ; Szer J; Doocey R; Lewis ID; Huebsch L; Howson-Jan K; Lalancette M; Almohareb F; Chaudhri N; Ivison S; Broady R; Levings M; Fairclough D; Devins G; Szwajcer D; Foley R; Smith C; Panzarella T; Kerr H; Kariminia A; Schultz KR
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1410-1415. PubMed ID: 27154847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia.
    Xu LP; Liu KY; Liu DH; Han W; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Wang JZ; Huang XJ
    Bone Marrow Transplant; 2012 Dec; 47(12):1507-12. PubMed ID: 22635243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia.
    Li Y; Jiang M; Xu C; Chen J; Li B; Wang J; Hu J; Ning H; Chen H; Chen S; Hu L
    Chin Med J (Engl); 2015 Jan; 128(1):20-4. PubMed ID: 25563308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study.
    Xu LP; Wang SQ; Ma YR; Gao SJ; Cheng YF; Zhang YY; Mo WJ; Mo XD; Zhang YP; Yan CH; Chen YH; Zhou M; Wang Y; Zhang XH; Liu KY; Huang XJ
    J Hematol Oncol; 2019 Sep; 12(1):87. PubMed ID: 31477147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.